Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24


STAT3 enhances the constitutive activity of AGC kinases in melanoma by transactivating PDK1.

Picco ME, Castro MV, Quezada MJ, Barbero G, Villanueva MB, Fernández NB, Kim H, Lopez-Bergami P.

Cell Biosci. 2019 Jan 3;9:3. doi: 10.1186/s13578-018-0265-8. eCollection 2019.


RACK1 cooperates with NRASQ61K to promote melanoma in vivo.

Campagne C, Reyes-Gomez E, Picco ME, Loiodice S, Salaun P, Ezagal J, Bernex F, Commère PH, Pons S, Esquerre D, Bourneuf E, Estellé J, Maskos U, Lopez-Bergami P, Aubin-Houzelstein G, Panthier JJ, Egidy G.

Cell Signal. 2017 Aug;36:255-266. doi: 10.1016/j.cellsig.2017.03.015. Epub 2017 Mar 24.


Correction for Zhang et al., RACK1 Recruits STAT3 Specifically to Insulin and Insulin-Like Growth Factor 1 Receptors for Activation, Which Is Important for Regulating Anchorage-Independent Growth.

Zhang W, Zong CS, Hermanto U, Lopez-Bergami P, Ronai Z, Wang LH.

Mol Cell Biol. 2017 Mar 1;37(6). pii: e00656-16. doi: 10.1128/MCB.00656-16. Print 2017 Mar 15. No abstract available.


Filamin A Expression Negatively Regulates Sphingosine-1-Phosphate-Induced NF-κB Activation in Melanoma Cells by Inhibition of Akt Signaling.

Campos LS, Rodriguez YI, Leopoldino AM, Hait NC, Lopez Bergami P, Castro MG, Sanchez ES, Maceyka M, Spiegel S, Alvarez SE.

Mol Cell Biol. 2015 Nov 9;36(2):320-9. doi: 10.1128/MCB.00554-15. Print 2016 Jan 15.


ROR1 contributes to melanoma cell growth and migration by regulating N-cadherin expression via the PI3K/Akt pathway.

Fernández NB, Lorenzo D, Picco ME, Barbero G, Dergan-Dylon LS, Marks MP, García-Rivello H, Gimenez L, Labovsky V, Grumolato L, Lopez-Bergami P.

Mol Carcinog. 2016 Nov;55(11):1772-1785. doi: 10.1002/mc.22426. Epub 2015 Oct 28.


β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.

Grumolato L, Liu G, Haremaki T, Mungamuri SK, Mong P, Akiri G, Lopez-Bergami P, Arita A, Anouar Y, Mlodzik M, Ronai ZA, Brody J, Weinstein DC, Aaronson SA.

PLoS Genet. 2013;9(8):e1003603. doi: 10.1371/journal.pgen.1003603. Epub 2013 Aug 15.


The role of mitogen- and stress-activated protein kinase pathways in melanoma.

Lopez-Bergami P.

Pigment Cell Melanoma Res. 2011 Oct;24(5):902-21. doi: 10.1111/j.1755-148X.2011.00908.x. Review.


The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand.

Yang NY, Lopez-Bergami P, Goydos JS, Yip D, Walker AM, Pasquale EB, Ethell IM.

Pigment Cell Melanoma Res. 2010 Oct;23(5):684-7. doi: 10.1111/j.1755-148X.2010.00745.x. Epub 2010 Jul 23. No abstract available.


Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Lopez-Bergami P, Lau E, Ronai Z.

Nat Rev Cancer. 2010 Jan;10(1):65-76. doi: 10.1038/nrc2681. Review. Erratum in: Nat Rev Cancer. 2010 May;10(5):379.


c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesis.

Lopez-Bergami P, Kim H, Dewing A, Goydos J, Aaronson S, Ronai Z.

J Biol Chem. 2010 Jan 8;285(2):903-13. doi: 10.1074/jbc.M109.075630. Epub 2009 Nov 12.


The long arm of BRAF V600E gets to mTORC1.

Lopez-Bergami P.

Pigment Cell Melanoma Res. 2009 Jun;22(3):244-5. doi: 10.1111/j.1755-148X.2009.00566.x. Epub 2009 Mar 18. No abstract available.


Requirements for PKC-augmented JNK activation by MKK4/7.

Lopez-Bergami P, Ronai Z.

Int J Biochem Cell Biol. 2008;40(5):1055-64. doi: 10.1016/j.biocel.2007.11.011. Epub 2007 Dec 3.


Understanding signaling cascades in melanoma.

Lopez-Bergami P, Fitchman B, Ronai Z.

Photochem Photobiol. 2008 Mar-Apr;84(2):289-306. Epub 2007 Dec 15. Review.


ATF2 on the double - activating transcription factor and DNA damage response protein.

Bhoumik A, Lopez-Bergami P, Ronai Z.

Pigment Cell Res. 2007 Dec;20(6):498-506. Review.


Rewired ERK-JNK signaling pathways in melanoma.

Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, Ronai Z.

Cancer Cell. 2007 May;11(5):447-60.


RACK1 mediates activation of JNK by protein kinase C [corrected].

López-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, Ronai Z.

Mol Cell. 2005 Aug 5;19(3):309-20. Erratum in: Mol Cell. 2005 Aug 19;19(4):578-9.


FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface.

Ivanov VN, Lopez Bergami P, Maulit G, Sato TA, Sassoon D, Ronai Z.

Mol Cell Biol. 2003 May;23(10):3623-35.


Sequence analysis, expression, and paratope characterization of a single-chain Fv fragment for the eukaryote ribosomal P proteins.

López Bergami P, Mateos P, Hoebeke J, Levin MJ, Baldi A.

Biochem Biophys Res Commun. 2003 Feb 21;301(4):819-24.


Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic.

López Bergami P, Scaglione J, Levin MJ.

FASEB J. 2001 Dec;15(14):2602-12.


Towards the physical map of the Trypanosoma cruzi nuclear genome: construction of YAC and BAC libraries of the reference clone T. cruzi CL-Brener.

Ferrari I, Lorenzi H, Santos MR, Brandariz S, Requena JM, Schijman A, Vázquez M, da Silveira JF, Ben-Dov C, Medrano C, Ghío S, López Bergami P, Cano I, Zingales B, Urmenyi TP, Rondinelli E, González A, Cortes A, Lopez MC, Thomas MC, Alonso C, Ramírez JL, Chiurrillo MA, Aldao RR, Levin MJ, et al.

Mem Inst Oswaldo Cruz. 1997 Nov-Dec;92(6):843-52.


Immunization with recombinant Trypanosoma cruzi ribosomal P2beta protein induces changes in the electrocardiogram of immunized mice.

Lopez Bergami P, Cabeza Meckert P, Kaplan D, Levitus G, Elias F, Quintana F, Van Regenmortel M, Laguens R, Levin MJ.

FEMS Immunol Med Microbiol. 1997 May;18(1):75-85.


Prevalence of anti-R-13 antibodies in human Trypanosoma cruzi infection.

Aznar C, Lopez-Bergami P, Brandariz S, Mariette C, Liegeard P, Alves MD, Barreiro EL, Carrasco R, Lafon S, Kaplan D, et al.

FEMS Immunol Med Microbiol. 1995 Dec;12(3-4):231-8.


Supplemental Content

Loading ...
Support Center